| Zhouhan Hu | 上海中医药大学 | Drug-Drug Interaction (DDI) Based Personalized Medication: Challenges and Solutions |
| Rulei Chen | 嘉和生物药业有限公司 | To foster biopharmaceutical innovation thru cross-Pacific Ocean collaboration |
| Qinghe Ding | 连云港经济技术开发区新医药和生物技术产业招商局 | Innovative combined effect of anticancer drugs |
| Chunlin Zhao | 北极光创投 | Entrepreneurial and Investment Opportunities in Life science and Healthcare Related Field in China |
| Heng Hong | 美国东卡罗来纳大学布洛迪医学院 | New challenges for fine needle aspiration cytology at the age of personalized treatment of lung canc |
| Junjian Chen | 加拿大麦克吉尔大学健康中心外科 | Highly specific molecular markers for noninvasive detection of high-risk prostate cancer |
| Shuqun Cheng | 上海东方肝胆医院肝外六科 | Classification and Surgery for Hepatocellular Carcinoma (HCC) with Portal Vein Tumor Thrombosis |
| Jun Zhang | 中国医科大学附属第一医院胸外科 | HDGF and ADAM9 as novel molecular staging biomarkers and prognostic biomarkers predicting the necess |
| Tianfu Wen | 四川大学华西医院肝胆外科 | Discussion about the Liver Transplantation Standard |
| Tomasz Rozmyslowicz | 美国宾夕法尼亚大学佩雷尔曼医学院 | Novel Diagnostic Techniques for Cancer Detection and Monitoring |
| Domenico D’Arca | 意大利摩德纳雷焦艾米利亚大学生物医学科学系 | TOSTATIN: a “Guardian of Mitochondrial integrity” in prostate gland. |
| 罗文 | 索元生物医药（杭州）有限公司 | Novel Biomarker Guided Therapy in Treating Lung Cancer - An Innovative Path to Accelerate New Drug |
| Andrzej Deptala | 波兰内政部中央临床医院肿瘤学和血液学科 | Microsatellite instability (MSI) as a new marker for prognosis, prediction, and individualization of |
| Hiroaki Ito | 日本昭和大学北部横滨市医院消化疾病中心消化外科 | Development of novel proteomic analysis by using Surface Enhanced Raman Scattering |
| Xun Ye | 复旦大学附属肿瘤医院梅里埃实验室研究所 | Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer |
| Peng Wang | 复旦大学附属肿瘤医院中西医结合科 | microRNAs as predictive biomarkers for human pancreatic cancer |
| Ling Dong | 复旦大学附属中山医院消化科 | early diagnosis biomarkers of liver cancer |
| Woei Ping Cheng | 英国赫特福德大学生命科学学院药学系 | Intelligent nano-carriers as an emerging platform for cancer therapy |
| Hudan Liu | 武汉华中科技大学同济医学院药学院 | Therapeutic Targeting of the Notch1 Signaling Pathway in Acute T-cell Lymphoblastic Leukemia |
| George G Chen | 香港中文大学威尔士亲王医院外科研究实验室 | Thromboxane and its receptor, potential novel targets in treatment of smoking-related lung cancer |
| Shudong Wang | 澳大利亚南澳大学药学和医疗科学学院药物化学系 | Targeting cancer with small molecule kinase inhibitors |
| Zhiren Fu | 第二军医大学附属长征医院肝移植科 | A New tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation |
| Henry Q.X. Li | 美国皇冠生物科技公司转化肿瘤部门 | Patient stratification of Erbitux treatment by mouse clinical trial (MCT, or HuTrialTM) |
| Yaoshan Fan | 美国佛罗里达州迈阿密大学病理科 | Treatment of lung cancer and companion diagnostic testing: Is there an Achilles heel for targeting? |
| Hua Liu | 复旦大学附属中山医院 | Cytotoxic T Lymphocytes and Antibody-based Therapeutics for the Treatment of Cancer |
| Jingbo Kang | 北京海军总医院放射肿瘤科 | Diagnosis and treatment strategies for recurrent glioma |
| Linghua Meng | 中国科学院上海药物研究所药理一室肿瘤药理 | The resistance mechanism and overcoming strategy about mTOR inhibitors |
| Ming Kuang | 广州中山大学附属第一医院肝胆外科 | Autocrine VEGF signaling promotes cell proliferation and modulates the sorafenib treatment efficacy |